Handling death as an intercurrent event in time to recovery analysis in COVID-19 treatment clinical trials
In clinical trials with the objective to evaluate the treatment effect on time to recovery, such as investigational trials on therapies for COVID-19 hospitalized patients, the patients may face a mortality risk that competes with the opportunity to recover (e.g., be discharged from the hospital). Th...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Inc.
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |